Samrat Pharmachem Ltd.
Snapshot View

428.90 +20.75 ▲5.1%

22 March 2023, 11:46:00 AM
Volume: 3,776

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.samratpharmachem.com
Market Cap 128.22 Cr.
Enterprise Value(EV) 154.74 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 78.88 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 5.26 Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share 207.77 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.00 Calculated using Price: 415.00
Dividend Yield 0.24 Period Ending 2022-03
No. of Shares Subscribed 0.31 Cr. 3,089,700 Shares
FaceValue 10
Company Profile
Samrat Pharmachem was incorporated on June 16, 1992, at Ankleshwar in Gujarat. It was promoted by Lalit Mehta & Rajesh Mehta. The company is currently manufacturing iodine salts & bromine salts. The finished products produced by the company are used in various industries like Pharmaceuticals, Chemicals, Food, Fertilizer, Salt, etc. The products of the company are well received in Indian & foreign markets. The company is a public limited company & its shares are listed & traded on the Bombay Stock Exchange & other bourses of India. The company is presently employing 30 people for its operations at Ankleshwar & Mumbai.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+5.08%
1 Week
-7.02%
1 Month
-13.48%
3 Month
-43.39%
6 Month
-61.29%
1 Year
-11.57%
2 Year
+201.41%
5 Year
+220.67%
10 Year
+1650.61%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 1.86 2.38 2.21 12.07 19.01 7.96 19.10 19.77 44.95
Return on Capital Employed (%) 6.93 6.45 5.31 16.40 23.05 11.80 22.43 23.90 52.33
Return on Assets (%) 0.74 1.10 0.97 4.86 8.37 3.79 8.60 9.22 24.20

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 13 13 14 15 19 20 24 30 47 62
Non Curr. Liab. 1 1 2 2 1 1 0 0 0 7
Curr. Liab. 17 12 20 19 21 19 34 27 37 42
Minority Int.
Equity & Liab. 31 26 36 36 41 40 58 57 85 111
Non Curr. Assets 8 8 8 8 8 7 9 10 11 12
Curr. Assets 24 18 28 28 33 33 50 47 74 99
Misc. Exp. not W/O
Total Assets 31 26 36 36 41 40 58 57 85 111

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 66 48 63 73 93 111 137 179 222 302
Other Income 1 0 0 0 0 0 1 0 1 0
Total Income 67 49 63 73 93 112 138 179 222 302
Total Expenditure -66 -47 -62 -69 -87 -108 -131 -170 -197 -267
PBIDT 1 2 1 4 6 4 7 9 25 35
Interest -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Depreciation 0 0 0 0 0 0 0 0 -1 -1
Taxation 0 0 0 -1 -2 -1 -2 -2 -6 -9
Exceptional Items 0 0 0 0 0
PAT 0 0 0 2 3 2 4 5 17 24
Adjusted EPS 1 1 1 6 10 5 14 17 56 79

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -2 4 -1 0 -3 0 2 -1 5 18
Cash Fr. Inv. -1 0 0 -2 1 -2 2 -2 -3 -1
Cash Fr. Finan. 1 -1 0 2 1 2 -4 2 -2 -2
Net Change -2 2 0 0 -1 -1 1 -1 0 14
Cash & Cash Eqvt 0 2 2 4 2 1 2 0 0 15

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 49.13 49.30 49.30 49.30 49.65 49.65 49.65 49.54 48.64
Public 50.87 50.70 50.70 50.70 50.35 50.35 50.35 50.46 51.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 17 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed the intimation letter dated March 16 2023 received from our Registrar and Share Transfer Agent Link Intime India Private Limited providing information regarding issue of duplicate share certificates to the shareholder(s) of the Company. The information is being submitted pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Thu, 16 Mar 2023
Board Meeting Outcome for Outcome Of Board Meeting Held Today
We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Thursday March 16 2023 has appointed the following Directors on the recommendation of the Nomination and Remuneration Committee details of which are as under:1. Mr. Lalit Mehta (DIN: 00216681) re-appointed as the Chairman & Managing Director of the Company for a period of 3 years commencing from 1st April 20232. Mr. Rajesh Mehta (DIN: 00216731) re-appointed as the Executive Director of the Company for a period of 3 years commencing from 1st April 20233. Mr. Megh Mehta (DIN: 07287394) re-appointed as the Executive Director of the Company for a period of 3 years commencing from 1st April 2023The Board has adopted Succession Planning Policy under Regulation 17(4) of the Securities and Exchange Board of India (LODR) Regulations 2015 effective from 16th March 2023.The meeting of the Board of Directors of the Company commenced at 14:00 hrs and concluded at 15:30 hrs.
Mon, 13 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby furnish the details of loss of share certificates/ request for issue of duplicate share certificate received from our Registrar and Share Transfer Agent Link Intime India Private Limited on March 10 2023.

Technical Scans View Details >>

Tue, 21 Mar 2023
Opening at High Opening at High
Opening at High for 3 days Opening at High for 3 days
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 961.05 +0.5%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,437.10 +0.4%
Divi's Laboratories Ltd. 73,553.38 2,777.00 +0.3%
Cipla Ltd. 69,632.88 854.95 -0.9%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,229.00 -1.0%
Torrent Pharmaceuticals Ltd. 51,277.87 1,506.55 -0.6%
Zydus Lifesciences Ltd. 48,378.30 479.10 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 961.05 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,437.10 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,777.00 +0.3%
Cipla Ltd. Consolidated 2022-12 26.39 854.95 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,229.00 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,506.55 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 479.10 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 961.05 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,437.10 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,777.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.07 854.95 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,229.00 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,506.55 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 479.10 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 961.05 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,437.10 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,777.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 854.95 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,229.00 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,506.55 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.10 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 961.05 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,437.10 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,777.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 854.95 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,229.00 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,506.55 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.10 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 961.05 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,437.10 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,777.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 854.95 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,229.00 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,506.55 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.10 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 961.05 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,437.10 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,777.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 854.95 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,229.00 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,506.55 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.10 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 961.05 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,437.10 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,777.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 854.95 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,229.00 -1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,506.55 -0.6%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.10 +0.2%

FAQ's On Samrat Pharmachem Ltd.

What is Samrat Pharmachem share price?

Can I buy Samrat Pharmachem shares now?

What is the Dividend Yield of Samrat Pharmachem?

What is the Market Cap of Samrat Pharmachem?

What are the key metrics to analyse Samrat Pharmachem?

What is the 52 Week High and Low of Samrat Pharmachem?

What is the trend of Samrat Pharmachem share price?